Since a number of studies have revealed HIF-1α overexpression to be significantly associated with poor prognoses in certain solid tumors, including pancreatic cancer, breast cancer, rectal adenocarcinoma and cervical cancer (26–29), it was investigated whether HIF-1α may function as a prognostic factor of TSCC. The gene discussed is HIF1A; the disease is breast cancer.